CCND1 and intrahepatic cholangiocarcinoma: The results showed that overexpression of CAMKK2 increased the expression levels of β-catenin, p-β-catenin and CCND1 proteins in vitro. At the same time, we treated two ICC cell lines overexpressing CAMKK2 with bufalin.